Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Mathews WR"'
Autor:
Laskey Re, Mathews Wr
Publikováno v:
Archives of biochemistry and biophysics. 330(1)
Lipid peroxidation is a component of various pathologies associated with nitric oxide (NO). It has been suggested thatin vivoproduction of peroxynitrite (ONOO−) is responsible for the detrimental effects of pathologies associated with NO. To invest
Autor:
Mathews Wr
Publisher Summary The chapter presents a study on analysis of leukotriene B 4 by quantitative gas chromatography-mass spectrometry (GC-MS). The chapter describes a GC-NCI (negative-ion chemical ionization)-MS assay for LTB 4 employing [ 2 H 4 ] LTB 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c8cfd707a667812b69bf00f2e54329b
https://doi.org/10.1016/0076-6879(90)87011-q
https://doi.org/10.1016/0076-6879(90)87011-q
Autor:
Harder BJ; Department of Translational Medicine, South San Francisco, California, USA., Lekkerkerker AN; Department of Translational Medicine, South San Francisco, California, USA., Casavant EP; Department of Translational Medicine, South San Francisco, California, USA., Hackney JA; Department of Translational Medicine, South San Francisco, California, USA., Nguyen A; Department of Translational Medicine, South San Francisco, California, USA., McBride JM; Department of Translational Medicine, South San Francisco, California, USA., Mathews WR; Department of Translational Medicine, South San Francisco, California, USA., Anania VG; Department of Translational Medicine, South San Francisco, California, USA.
Publikováno v:
Proteomics. Clinical applications [Proteomics Clin Appl] 2024 Sep; Vol. 18 (5), pp. e2300075. Date of Electronic Publication: 2024 Mar 29.
Autor:
Perez-Paramo YX; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Dufield D; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Veeramachaneni R; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Parkhurst E; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Harp C; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Ramesh A; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Winger RC; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Cross AH; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Gelfand JM; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Bar-Or A; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Mathews WR; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.)., Anania VG; Department of Translational Medicine, Genentech, Inc., South San Francisco, California (Y.X.P.-P., C.H., A.R., R.C.W., W.R.M., V.G.A.); KCAS Bioanalytical Sciences, Olathe, Kansas (D.D., R.V., E.P.); Washington University School of Medicine, St Louis, Missouri (A.H.C.); University of California, San Francisco, California (J.M.G.); and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.B.-O.) anania.veronica@gene.com.
Publikováno v:
Molecular pharmacology [Mol Pharmacol] 2024 Feb 15; Vol. 105 (3), pp. 121-130. Date of Electronic Publication: 2024 Feb 15.
Autor:
Casavant EP; Genentech, South San Francisco, CA, USA., Liang J; Genentech, South San Francisco, CA, USA., Sankhe S; Genentech, South San Francisco, CA, USA., Mathews WR; Genentech, South San Francisco, CA, USA., Anania VG; Genentech, South San Francisco, CA, USA. anania.veronica@gene.com.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2603, pp. 245-257.
Autor:
Lill JR; Department of Microchemistry, Lipidomics and Next Generation Sequencing, Genentech Inc. DNA Way, South San Francisco, CA, USA., Mathews WR; OMNI Department, Genentech Inc. 1 DNA Way, South San Francisco, CA, USA., Rose CM; Department of Microchemistry, Lipidomics and Next Generation Sequencing, Genentech Inc. DNA Way, South San Francisco, CA, USA., Schirle M; Chemical Biology and Therapeutics Department, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Publikováno v:
Expert review of proteomics [Expert Rev Proteomics] 2021 Jul; Vol. 18 (7), pp. 503-526. Date of Electronic Publication: 2021 Aug 12.
Autor:
Banchereau R; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Chitre AS; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA., Scherl A; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA., Wu TD; Department of Bioinformatics and Computational Biology, Genentech Inc, South San Francisco, California, USA., Patil NS; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., de Almeida P; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA.; Adaptive Biotechnologies Corp South San Francisco, South San Francisco, California, USA., Kadel Iii EE; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Madireddi S; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA., Au-Yeung A; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA., Takahashi C; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA., Chen YJ; Department of Microchemistry, Proteomics, Lipidomics, and Next Generation Sequencing, Genentech Inc, South San Francisco, California, USA.; Analytical Biosciences Limited, South San Francisco, California, USA., Modrusan Z; Department of Microchemistry, Proteomics, Lipidomics, and Next Generation Sequencing, Genentech Inc, South San Francisco, California, USA., McBride J; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA., Nersesian R; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., El-Gabry EA; Ventana Medical Systems Inc, Tucson, Arizona, USA., Robida MD; Ventana Medical Systems Inc, Tucson, Arizona, USA., Hung JC; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA., Kowanetz M; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA.; Bolt Biotherapeutics, Redwood City, California, USA., Zou W; Department of Biostatistics Oncology, Genentech Inc, South San Francisco, California, USA., McCleland M; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Caplazi P; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA., Eshgi ST; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA., Koeppen H; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA., Hegde PS; Foundation Medicine, Cambridge, Massachusetts, USA., Mellman I; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA., Mathews WR; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA., Powles T; Barts Cancer Center, Queen Mary University, London, UK., Mariathasan S; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA ogormanw@gene.com jane.grogan@gmail.com sanj@gene.com., Grogan J; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA ogormanw@gene.com jane.grogan@gmail.com sanj@gene.com., O'Gorman WE; Department of OMNI Biomarker Development, Genentech Inc, South San Francisco, California, USA ogormanw@gene.com jane.grogan@gmail.com sanj@gene.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).
Autor:
Anania VG; Department of Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Randolph AG; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.; Departments of Anaesthesia and Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Yang X; Department of Biostatistics, Genentech, Inc., South San Francisco, California, USA., Nguyen A; Department of Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Newhams MM; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts, USA., Mathews WR; Department of Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Rosenberger CM; Department of Biomarker Discovery, Genentech, Inc., South San Francisco, California, USA., McBride JM; Department of Biomarker Development, Genentech, Inc., South San Francisco, California, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Apr 09; Vol. 7 (5), pp. ofaa122. Date of Electronic Publication: 2020 Apr 09 (Print Publication: 2020).
Autor:
Toghi Eshghi S; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Au-Yeung A; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Takahashi C; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Bolen CR; Bioinformatics, Genentech Inc., South San Francisco, CA, United States., Nyachienga MN; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Lear SP; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Green C; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., Mathews WR; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States., O'Gorman WE; OMNI Biomarker Development, Genentech Inc., South San Francisco, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Jun 05; Vol. 10, pp. 1194. Date of Electronic Publication: 2019 Jun 05 (Print Publication: 2019).
Autor:
Anania VG, Yu K, Pingitore F, Li Q, Rose CM, Liu P, Sandoval W, Herman AE, Lill JR, Mathews WR
Publikováno v:
Journal of proteome research [J Proteome Res] 2019 Mar 01; Vol. 18 (3), pp. 1264-1277. Date of Electronic Publication: 2019 Jan 03.